UBS Lux Equity Fund Biotech USD vs T. Rowe Price US Large Cap Growth Equity Fund A USD

UBS Lux Equity Fund Biotech USD vs T. Rowe Price US Large Cap Growth Equity Fund A USD

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

2. T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Security

    T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Fee

    1.59%

  • ISIN

    LU0174119429

  • Holdings

    10

Fund Holdings

We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with T. Rowe Price US Large Cap Growth Equity Fund A USD, we have 20 holdings where Apple is the largest holding (9.63), followed by Nvidia (9.59) and Microsoft (9.49).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and T. Rowe Price US Large Cap Growth Equity Fund A USD.

UBS Lux Equity Fund Biotech USD T. Rowe Price US Large Cap Growth Equity Fund A USD
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Apple Inc
USA
9.63 %
2. Moderna Inc
9.21 %
2. Nvidia Corp
USA
9.59 %
3. Vertex Pharmaceuticals Inc
8.44 %
3. Microsoft Corp
USA
9.49 %
4. Alnylam Pharmaceuticals Inc
8.08 %
4. Amazon.com Inc
USA
5.85 %
5. AbbVie Inc
USA
4.91 %
5. Meta Platforms A
USA
4.85 %
6. Gilead Sciences Inc
USA
4.66 %
6. Alphabet Inc Class A
USA
4.65 %
7. Amgen Inc
USA
4.43 %
7. Broadcom Inc
USA
3.68 %
8. BioNTech SE
4.13 %
8. Mastercard Inc
USA
3.51 %
9. Karuna Therapeutics Inc
3.75 %
9. Intuit Inc
3.29 %
- 10. ServiceNow Inc
USA
3.25 %

The list of fund holdings was last updated on July 25, 2025.